Application of Lipidomics to Assess Lipogenesis in Drug Development and Pre-Clinical Trials

Publisher： Bentham Science Publishers

E-ISSN： 1873-4316|13|5|736-745

ISSN： 1389-2010

Source： Current Pharmaceutical Biotechnology, Vol.13, Iss.5, 2012-04, pp. : 736-745

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Positron Emitting Tracers in Pre-Clinical Drug Development

By  

Current Radiopharmaceuticals, Vol. 5, Iss. 2, 2012-04 ,pp. : 90-98

Bentham Science Publishers

Access to resources Recommend Favorite

Statins and epilepsy: preclinical studies, clinical trials and statin-anticonvulsant drug interactions

By  

Current Drug Targets, Vol. 16, Iss. 7, 2015-01 ,pp. : 747-756

Bentham Science Publishers

Access to resources Recommend Favorite

Hematotoxicity Testing by Cell Clonogenic Assay in Drug Development and Preclinical Trials

By  

Current Pharmaceutical Design, Vol. 11, Iss. 8, 2005-03 ,pp. : 1055-1065

Bentham Science Publishers

Access to resources Recommend Favorite

Clinical-Pharmacological Strategies to Assess Drug Interaction Potential During Drug Development

By Kuhlmann J.   Mück W.  

Drug Safety, Vol. 24, Iss. 10, 2001-01 ,pp. : 715-725

Adis International

Access to resources Recommend Favorite

TRAIL Gene Therapy: From Preclinical Development to Clinical Application

By  

Current Gene Therapy, Vol. 9, Iss. 1, 2009-02 ,pp. : 9-19

Bentham Science Publishers

Access to resources Recommend Favorite